ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "patient preferences"

  • Abstract Number: 2249 • 2019 ACR/ARP Annual Meeting

    Evaluation of Rheumatoid Arthritis Patients’ Preferences Using Discrete Choice Experiment

    Aniket Kawatkar1, 1Kaiser Permanente Southern California, Pasadena, CA

    Background/Purpose: Rheumatoid arthritis (RA) exerts multifaceted burden through medical expenditures, productivity losses, disability, and intangible costs of pain, fatigue, and loss of functional capacity. Patient…
  • Abstract Number: 2251 • 2019 ACR/ARP Annual Meeting

    Understanding Vulnerabilities in Diagnosis and Care of Childhood and Adult-Onset Lupus: A Qualitative Study

    Siobhan Case1, Corine Sinnette 2, Courtnie Phillip 2, Claire Grosgogeat 3, Karen Costenbader 2, Cianna Leatherwood 4, Candace Feldman 2 and Mary Beth Son 3, 1Brigham and Women's Hospital and Boston Children's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Boston Children's Hospital, Boston, MA, 4Kaiser Permanente, San Francisco, CA

    Background/Purpose: Systemic lupus erythematosus (SLE) poses complex diagnostic and management challenges, which may differ depending on whether SLE was diagnosed in childhood (cSLE) or in…
  • Abstract Number: 2254 • 2019 ACR/ARP Annual Meeting

    The Urge for Mobile Apps in Rheumatology – a German Patient Perspective

    Johannes Knitza1, Christina Raab 1, Antonia Lambrecht 1, David Simon 2, Melanie Hagen 1, Sara Bayat 1, Georg Schett 3, Arnd Kleyer 1 and Axel Hueber 4, 1Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany, Erlangen, Germany, 2Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Bayern, Germany, 3Department of Internal Medicine 3, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany, 4Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany; Sektion Rheumatologie, Sozialstiftung Bamberg, Klinikum Bamberg, Bamberg, Germany, Erlangen, Germany

    Background/Purpose: Mobile health applications have the potential of saving costs, empowering patients and improving treatment outcomes. Furthermore, the use of medical apps in routine care…
  • Abstract Number: 1394 • 2018 ACR/ARHP Annual Meeting

    Development and Pilot of a Patient Satisfaction Scale in Rheumatology

    Antonia Valenzuela1, Khushboo Sheth2, Stanford Shoor2, Philip L. Ritter2 and Kate Lorig3, 1Immunology and Rheumatology, Stanford University, Palo Alto, CA, 2Immunology & Rheumatology, Stanford University, Palo Alto, CA, 3Stanford University, Palo Alto, CA

    Background/Purpose: Patient satisfaction has been studied as a performance improvement measure in clinical practice among patients with a variety of diseases, but to date there…
  • Abstract Number: 2343 • 2018 ACR/ARHP Annual Meeting

    Exploring Decision Making Needs about Pain Management Among Adolescents with Juvenile Idiopathic Arthritis and Their Families: Preliminary Results from Interviews

    Karine Toupin-April1, Jennifer N. Stinson2, Adam Huber3,4, Ciarán M. Duffy5, Isabelle Gaboury6, Esi Morgan7,8, Lucie Brosseau9, William Brinkman7,8, Linda Li10, Tania El Hindi11, Aditi Sivakumar11, Marg Bisch12, Janice Cohen13, Elizabeth Stringer14, France Légaré15, Laurie Proulx16, Paul R. Fortin17 and Peter Tugwell18, 1Children’s Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, 2Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, ON, Canada, 3IWK Health Centre, Halifax, NS, Canada, 4Dalhousie University, Halifax, NS, Canada, 5Children's Hospital of Eastern Ontario and University of Ottawa, Ottawa, ON, Canada, 6Universite de Sherbrooke, Sherbrooke, ON, Canada, 7Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 8University of Cincinnati, Cincinnati, OH, 9University of Ottawa, Ottawa, ON, Canada, 10Arthritis Research Canada, Richmond, BC, Canada, 11Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada, 12Children's Hospital of Eastern Ontario, Ottawa, ON, Canada, 13Children's Hospital of Eastern Ontario Research Institute, ottawa, ON, Canada, 14Department of Rheumatology, IWK Health Centre, Halifax, NS, Canada, 15Laval University, Montreal, QC, Canada, 16Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, 17Medicine, CHU de Québec - University of Laval, Quebec, QC, Canada, 18Center For Global Health, Institute of Population Hlth, Ottawa, ON, Canada

    Background/Purpose: Adolescents with juvenile idiopathic arthritis (JIA), one of the most common causes of chronic musculoskeletal pain among youth, face many difficult decisions. However, we…
  • Abstract Number: 2344 • 2018 ACR/ARHP Annual Meeting

    Treatment Modes in Rheumatoid Arthritis: Moving Toward Shared Decision-Making

    Peter C. Taylor1, Neil Betteridge2, T Michelle Brown3, John Woolcott4, Alan J. Kivitz5, Cristiano A F Zerbini6, Diane Whalley7, Oyebimpe Olayinka-Amao3, Connie Chen8, Palle Dahl9, Dario Ponce de Leon10, David Gruben11 and Lara Fallon12, 1University of Oxford, Oxford, United Kingdom, 2Neil Betteridge Associates, London, United Kingdom, 3RTI Health Solutions, Research Triangle Park, NC, 4Pfizer Inc, Collegeville, PA, 5Altoona Center for Clinical Research, Duncansville, PA, 6Centro Paulista de Investigação Clinica, São Paulo, Brazil, 7RTI Health Solutions, Manchester, United Kingdom, 8Pfizer Inc, New York, NY, 9Pfizer Inc, Ballerup, Denmark, 10Pfizer Inc, Lima, Peru, 11Pfizer Inc, Groton, CT, 12Pfizer Canada, Montreal, QC, Canada

    Background/Purpose: Treatment recommendations in RA emphasize shared decision-making,1 but little is known about patient (pt) perspectives. Through qualitative research, we aim to understand pt preferences…
  • Abstract Number: 2351 • 2018 ACR/ARHP Annual Meeting

    Attitudes Toward Telehealth Video Conferencing Among Patients with Rheumatic Disease

    Dawen Zhang1,2, Jennifer Lu2, Cleopatra Aquino- Beaton2, Nancy Harada2 and Meika A. Fang1,2, 1UCLA Dept of Medicine, Division of Rheumatology, Los Angeles, CA, 2VA Greater Los Angeles Healthcare System, Los Angeles, CA

    Background/Purpose: Video Teleconferencing (VTC) telehealth is a synchronous medium in which patients may interact with physicians using their own personal electronic device or at a…
  • Abstract Number: 2366 • 2018 ACR/ARHP Annual Meeting

    Facilitating Shared Decision Making in Psoriatic Arthritis: Factors Influencing Patient Preference for Treatment Mode of Administration

    Daniel Aletaha1, M. Elaine Husni2, Joseph F. Merola3, Roberto Ranza4, Heidi Bertheussen5, Ralph Lippe6, Pamela Young7, Joseph C Cappelleri8, T Michelle Brown9, Claire Ervin9, Ming-Ann Hsu8 and Lara Fallon10, 1Medical University of Vienna, Vienna, Austria, 2Cleveland Clinic, Orthopedic and Rheumatologic Institute, Cleveland, OH, 3Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 4Servicio de Reumatología, Universidade Federal de Uberlandia, Santa Mônica, Uberlândia, Brazil, 5Patient Representative, Oslo, Norway, 6Pfizer Pharma GmbH, Berlin, Germany, 7Pfizer Inc, Collegeville, PA, 8Pfizer Inc, Groton, CT, 9RTI Health Solutions, Research Triangle Park, NC, 10Pfizer Canada, Montreal, QC, Canada

    Background/Purpose: Shared decision making is key to optimizing management of patients (pts) with psoriatic arthritis (PsA).1 Few studies have evaluated pt preferences for treatment administration…
  • Abstract Number: 2368 • 2018 ACR/ARHP Annual Meeting

    Patient Preferences for Disease Modifying Anti-Rheumatic Drug Treatment in Rheumatoid Arthritis: A Systematic Review

    Caylib Durand1, Maysoon Eldoma1, Deborah A. Marshall2 and Glen Hazlewood1,3, 1Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada, 2Community Health Sciences, University of Calgary, Calgary, AB, Canada, 3Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Treatment choices in rheumatoid arthritis (RA) involve trade-offs in risks, benefits and other considerations such as dosing. Understanding patient preferences for these trade-offs is…
  • Abstract Number: 2370 • 2018 ACR/ARHP Annual Meeting

    Physician and Patient Preferences for Treating SLE: Insights into the Choice of Intravenous Infusion and Subcutaneous Injection

    Matthew Lau1, Christopher F Bell1, Christine Poulos2 and Ameya Benegal3, 1GlaxoSmithKline, Research Triangle Park, NC, 2RTI Health Solutions, Research Triangle Park, NC, 3RTI Health Solutions, RTP, NC

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic, multisystem autoimmune disease characterized by diverse clinical manifestations, chronic inflammation, and significant morbidity that can be fatal1.…
  • Abstract Number: 2372 • 2018 ACR/ARHP Annual Meeting

    Social Media Use for Health-Related Purposes By People with Rheumatic and Musculoskeletal Diseases – Results of a Global Survey

    Paul Studenic1, Alessia Alunno2, Simon R Stones3, Valentin Ritschl4 and Elena Nikiphorou5, 1Division of Rheumatology, Department of Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 2Department of Medicine, Rheumatology Unit, University of Perugia, Perugia, Italy, 3School of Healthcare, University of Leeds, Leeds, United Kingdom, 4Center for Medical Statistics, Informatics, and Intelligent Systems, Section for Outcomes Research, Medical University of Vienna, Vienna, Austria, Vienna, Austria, 5Academic Rheumatology, Department of Inflammation Biology, King's College London, London, Great Britain

    Background/Purpose: Smartphone applications and social media (SM) are increasingly used, transforming the way in which people communicate. Peer interaction, remote information access and community building…
  • Abstract Number: 358 • 2017 ACR/ARHP Annual Meeting

    Patients and Physicians Have Different Perceptions of the Relative Bother of the Symptoms and Impacts on Daily Activities in Psoriasis and Psoriatic Arthritis

    M. Elaine Husni1,2, Anthony Fernandez1, Rakesh Singh3, Brett Hauber4, Jessie Sutphin4, Joshua Posner4 and Arijit Ganguli3, 1Cleveland Clinic, Cleveland, OH, 2Rheumatology Dept A50, Cleveland Clinic Foundation, Cleveland, OH, 3AbbVie Inc., North Chicago, IL, 4RTI Health Solutions, Research Triangle Park, NC

    Background/Purpose: Psoriasis and psoriatic arthritis arise from the same immune system response but result in different symptoms and impacts on daily activities. A patient with…
  • Abstract Number: 1252 • 2017 ACR/ARHP Annual Meeting

    Real-World Oral Methotrexate Adherence Measured Electronically in Patients with Established Rheumatoid Arthritis

    Kaleb Michaud1,2, Rebecca Schumacher2, Bernard Vrijens3, Eric Tousset3, Gorana Dasic4, Connie Chen4, Ekta Agarwal4 and Maria Suarez-Almazor5, 1University of Nebraska Medical Center, Omaha, NE, 2National Data Bank for Rheumatic Diseases, Wichita, KS, 3WestRock Healthcare, Visé, Belgium, 4Pfizer Inc, New York, NY, 5Section of Rheumatology and Clinical Immunology, Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA, Houston, TX

    Background/Purpose: While weekly methotrexate (MTX) remains the gold standard treatment for patients with RA, studies suggest that MTX adherence may be sub-optimal and could be…
  • Abstract Number: 1856 • 2017 ACR/ARHP Annual Meeting

    Patient and Physician Perspectives on Content Value for Educational Material Regarding Rare Rheumatic Diseases

    Chris Hatzis1, Elizabeth Soto-Cardona2, Jessica K. Gordon2 and Robert F. Spiera2, 1Medicine, Hospital for Special Surgery, New York, NY, 2Rheumatology, Hospital for Special Surgery, New York, NY

    Background/Purpose: Internet-based information is important for patients and their caregivers. For the past 4 years, our academic medical center’s Center for Scleroderma, Vasculitis & Myositis…
  • Abstract Number: 2782 • 2017 ACR/ARHP Annual Meeting

    Patient Beliefs and Preference to Initiate a Proposed Medication in Rheumatoid Arthritis

    Richard W Martin1, Rohit Nallani2, Andrew D Head1, Aaron T Eggebeen1, James D Birmingham1 and Eric T Slavin1, 1Medicine, Rheumatology, Michigan State University, College of Human Medicine, Grand Rapids, MI, 2Michigan State University, College of Human Medicine, Grand Rapids, MI

    Background/Purpose : Normative economic theory assumes that people making decisions have complete information of the options, rationally weigh the opportunity costs, expected outcomes and optimize…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology